Insider Selling: MAXIMUS, Inc. (NYSE:MMS) General Counsel Sells $502,985.28 in Stock

MAXIMUS, Inc. (NYSE:MMS) General Counsel David Francis sold 6,496 shares of the stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $77.43, for a total transaction of $502,985.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of MMS opened at $75.06 on Friday. The firm has a market capitalization of $4.93 billion, a PE ratio of 22.08, a PEG ratio of 2.07 and a beta of 0.87. The company’s 50-day moving average is $77.80 and its 200-day moving average is $74.00. MAXIMUS, Inc. has a fifty-two week low of $60.00 and a fifty-two week high of $82.02.

MAXIMUS (NYSE:MMS) last issued its quarterly earnings data on Thursday, August 8th. The health services provider reported $0.97 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.93 by $0.04. The company had revenue of $730.70 million for the quarter, compared to analyst estimates of $754.81 million. MAXIMUS had a net margin of 8.44% and a return on equity of 20.72%. The company’s revenue was up 22.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 earnings per share. As a group, sell-side analysts expect that MAXIMUS, Inc. will post 3.73 EPS for the current year.



A number of analysts have commented on MMS shares. Wells Fargo & Co reiterated a “market perform” rating and issued a $83.00 price target on shares of MAXIMUS in a research note on Friday, August 9th. Canaccord Genuity increased their price target on shares of MAXIMUS from $72.00 to $77.00 and gave the company a “hold” rating in a research note on Tuesday, August 13th. Finally, ValuEngine cut shares of MAXIMUS from a “buy” rating to a “hold” rating in a research note on Friday, June 28th.

Institutional investors and hedge funds have recently modified their holdings of the company. Allianz Asset Management GmbH raised its position in shares of MAXIMUS by 12.3% in the second quarter. Allianz Asset Management GmbH now owns 329,750 shares of the health services provider’s stock valued at $23,920,000 after purchasing an additional 36,225 shares during the period. Strs Ohio raised its position in shares of MAXIMUS by 7.5% in the second quarter. Strs Ohio now owns 10,000 shares of the health services provider’s stock valued at $725,000 after purchasing an additional 700 shares during the period. Amundi Pioneer Asset Management Inc. raised its position in shares of MAXIMUS by 13.6% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 168,969 shares of the health services provider’s stock valued at $89,411,000 after purchasing an additional 20,289 shares during the period. P2 Capital Partners LLC raised its position in shares of MAXIMUS by 1.0% in the second quarter. P2 Capital Partners LLC now owns 1,083,594 shares of the health services provider’s stock valued at $78,604,000 after purchasing an additional 11,000 shares during the period. Finally, Schroder Investment Management Group raised its position in shares of MAXIMUS by 1,307.8% in the second quarter. Schroder Investment Management Group now owns 54,904 shares of the health services provider’s stock valued at $3,983,000 after purchasing an additional 51,004 shares during the period. 94.79% of the stock is currently owned by institutional investors.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Featured Story: What does the Dogs of the Dow mean?

Insider Buying and Selling by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.